GSE230865 EYA2 knockdown 3 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE230865_EYA2 knockdown_3_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE230865_EYA2 knockdown_3_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE230865_EYA2 knockdown_3_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE230865_EYA2 knockdown_3_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

VPS9D1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 958

Gene

MPDU1 antisense RNA 1

Gene

uncharacterized LOC105372321

Gene

DPP10 antisense RNA 1

Gene

uncharacterized LOC254896

Gene

p53-induced noncoding RNA

Gene

ovarian adenocarcinoma amplified long non-coding RNA

Gene

uncharacterized LOC124904294

Gene

ZNF691 divergent transcript

  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 958


  • Gene

    MPDU1 antisense RNA 1


  • Gene

    uncharacterized LOC105372321


  • Gene

    DPP10 antisense RNA 1


  • Gene

    uncharacterized LOC254896


  • Gene

    p53-induced noncoding RNA


  • Gene

    ovarian adenocarcinoma amplified long non-coding RNA


  • Gene

    uncharacterized LOC124904294


  • Gene

    ZNF691 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.